Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis

Clinics

Volumn 66, Issue 8, 2011, Pages 1401-1406

  Yazbek, Michel Alexandre ^a   de Barros Mazon, Silvia ^a   Rossi, Cláudio Lúcio ^a   Londe, Ana Carolina ^a   Costallat, Lilian Tereza Lavras ^a   Bértolo, Manoel Barros ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Brazilians; Epstein Barr virus; Epstein Barr virus nuclear antigens; Rheumatoid arthritis; Risk factors

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; EPITOPE; EPSTEIN BARR VIRUS ANTIGEN; VIRUS ANTIBODY;

ADULT; AGED; ALLELE; ARTICLE; BLOOD; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; RHEUMATOID ARTHRITIS; RISK FACTOR; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANTIBODIES, VIRAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RISK FACTORS; SMOKING;

EID: 80052720014     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000800016     Document Type: Article

References (35)

1. Klareskog L, Catrina AI, Paget S. Rheumatoid Arthritis. Lancet. 2009;373:659-72, doi: 10.1016/S0140-6736(09)60008-8.
2. Plenge RM. Recent progress in rheumatoid arthritis genetics. Curr Opin Rheumatol. 2009;21:262-71, doi: 10.1097/BOR.0b013e32832a2e2d.
3. Rantapää-Dahlqvist S. What happens before onset of rheumatoid arthritis? Curr Opin Rheumatol. 2009;21:272-8, doi: 10.1097/BOR. 0b013e32832a2e44.
4. Liao KP, Alferdsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol. 2009;21:279-83, doi: 10.1097/ BOR.0b013e32832a2e16.
5. Lündstrom E, Källberg H, Alfredsson L, Klareskog L, Padyukov L. Geneenvironment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis-All alleles are important. Arthritis Rheum. 2009;60:1597-603, doi: 10.1002/art.24572.
6. Karlson EW, Chang S-C, Cui J, Chibnik LB, Fraser PA, De Vivo I. Geneenvironment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis. 2010;69:54-60, doi: 10.1136/ard.2008.102962.
7. Bang S-Y, Lee K-H, Cho S-K, Lee H-S, Lee KW, Bae S-C. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheum. 2010;62:369-77.
8. Linn-Rasker SP, van der Helm-van Mil AHM, van Gaalen FA, Kloppenburg M, de Vries RRP, le Cessie S, et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann rheum Dis. 2006;65:366-71, doi: 10.1136/ard.2005.041079.
9. Baka Z, Buzás E, Nagy G. Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res Ter. 2009;11:238-51, doi: 10.1186/ar2751.
10. Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54:38-46, doi: 10.1002/art.21575.
11. Vaughan JH. Viruses and autoimmune disease. J Rheumatol. 1996;23:1831-3.
12. Vaughan JH. The Epstein-Barr virus in autoimmunity. Springer Semin Immunopathol. 1995;17:203-30, doi: 10.1007/BF00196166.
13. Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22:883-96, doi: 10.1016/j.berh.2008.09.007.
14. Costenbader KH, Karlson EW. Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther. 2006;8:204, doi: 10.1186/ar1893.
15. Toussirot E, Roudier J. Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update. Joint Bone Spine. 2007;74:418-26, doi: 10.1016/j.jbspin.2007.05.001.
16. Inoue N, Harada S, Miyasaka N, Oya A, Yanagi K. Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjögren's syndrome and with rheumatoid arthritis. J Infect Dis. 1991;164:22-8, doi: 10.1093/infdis/164.1.22.
17. Silverman SL, Schumacher HR. Antibodies to Epstein-Barr viral antigens in early rheumatoid arthritis. Arthritis Rheum. 1981;24:1465-8, doi: 10.1002/art.1780241202.
18. Kouri T, Petersen J, Rhodes G, Aho K, Palusuo T, Heliövaara M, et al. Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. J Rheumatol. 1990;17:1442-9.
19. Petersen J, Rhodes G, Roudier J, Vaughan JH. Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 1990;33:993-1000, doi: 10.1002/art.1780330711.
20. Fox R, Sportsman R, Rhodes G, Luka J, Pearson G, Vaughan J. Rheumatoid arthritis synovial membrane contains a 62,000-molecularweight protein that shares an antigenic epitope with the Epstein-Barr virus encoded associated EBNA-1 antigen. J Clin Invest. 1986;77:1539-47, doi: 10.1172/JCI112469.
21. Baboonian C, Venables PJW, Williams DG, Williams RO, Maini RN. Cross-reaction of antibodies to a glycine/alanine repeat sequence of Epsteine Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin. Ann Rheum Dis. 1991;50:772-5, doi: 10.1136/ard.50.11.772.
22. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference, vol 1, Oxford: Oxford University Press. 1992:397-439.
23. Alpsaugh MA, Tan EM. Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence. Arthritis Rheum. 1976;19:711-9, doi: 10.1002/1529-0131(197607/08)19:4,711::AID-ART1780190409.3.0.CO;2-I.
24. Roudier J, Petersen J, Rhodes JH, Luka J, Carson DA. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci USA. 1989;86:5104-8, doi: 10.1073/pnas.86.13.5104.
25. Deblon N, Toussirot E, Auger I, Roudier J, Roudier C. Les proteins EBNA-1 et gp110 du virus d'Epstein Barr sont les cibles d'une forte réponse anticorps chez les patients atteints de polyarthrite rhumatoïde qui expriment l'épitope partagé. Rev Rhum. 2005;72:978-9.
26. Szodoray P, Szabó Z, Kapitány A, Gyetvai A, Lakos G, Szántó S, et al. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev. 2010;9:140-3, doi: 10.1016/j. autrev.2009.04.006.
27. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum. 2006;54:1117-21, doi: 10.1002/art.21739.
28. Anzilotti C, Merlini G, Pratesi F, Tommasi C, Chimenti D, Migliorini P. Antibodies to viral citrullinated peptide in rheumatoid arthritis. J Rheumatol. 2006;33:647-51.
29. Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum. 2006;54:733-41, doi: 10.1002/art.21629.
30. Simon KC, van der Mei IA, Munger KL, Ponsonby A, Dickinson J, Dwyer T, et al. Combined effects of smoking, anti-EBNA antibodies, and HLADRB1* 1501 on multiple sclerosis risk. Neurology. 2010;74:1365-71, doi:10.1212/WNL.0b013e3181dad57e.
31. De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology. 2008;25;70:1113-8.
32. Balandraud N, Meynard JB, Auger I, Sovran H, Mugneir B, Reviron D, et al. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis. Arhtritis Rheum. 2003;48:1223-8, doi: 10.1002/art.10933.
33. Anzilotti C, Riente L, Pratesi F, Chimenti D, Delle Sedie A, Bombardieri S, et al. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders. Rheumatology (Oxford). 2007;46:1579-82, doi: 10.1093/rheumatology/kem193.
34. Louzada-Junior P, Freitas MV, Oliveira RD, Deghaide NH, Conde RA, Bertolo MB, et al. A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies. Braz J Med Biol Res. 2008;41:493-9, doi: 10.1590/S0100-879X2008005000021.
35. Oliveira RD, Junta CM, Oliveira FR, Silva LM, Donadi EA, Louzada-Junior P. Share epitope, citrullinated cyclic peptide antibodies and smoking in Brazilian rheumatoid arthritis patients. Clin Rev Allergy Immunol. 2008;34:32-5, doi: 10.1007/s12016-007-8017-2.